Glyburide: all 69 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Metformin Versus Glyburide for Blood Sugar Control in Women With Gestational DiabetesRecruitingNCT07802561Phase 4
• OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNot yet recruitingNCT07221799Phase 1
• Comparison Between Metformin and Glyburide in the Management of Gestational DiabetesNot yet recruitingNCT06589141Not applicable
• Spinal Cord Injury Neuroprotection With GlyburideRecruitingNCT05426681Phase 1
• A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain ContusionTerminatedNCT03954041Phase 2Results posted
• Metabolic Analysis for Treatment Choice in Gestational Diabetes MellitusCompletedNCT03029702Phase 4Results posted
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric InfarctionTerminatedNCT02864953Phase 3Results posted
• Spinal Cord Injury Neuroprotection With GlyburideTerminatedNCT02524379Phase 1/2Results posted
• Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)TerminatedNCT02460874Phase 1/2Results posted
• Glyburide Advantage in Malignant Edema and Stroke PilotCompletedNCT01268683Phase 1/2Results posted
• Metformin Compared to Glyburide in Gestational DiabetesCompletedNCT00965991Not applicableResults posted
• Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FastingCompletedNCT00836472Phase 1Results posted
• Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, FedCompletedNCT00835991Phase 1Results posted
• Treatment of Mild Gestational Diabetes With Glyburide Versus PlaceboCompletedNCT00744965Phase 4Results posted
• Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00286468Phase 3Results posted
• Preservation of Beta-cell Function in Type 2 Diabetes MellitusCompletedNCT00232583Not applicableResults posted
• Preferred Treatment of Type 1.5 DiabetesCompletedNCT00194896Not applicableResults posted
• Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)CompletedNCT05687500Phase 2
• To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBIStatus unknownNCT05148403Phase 1/2
• Evaluate the Use of Glibenclamide on Acute aSAHStatus unknownNCT05137678Phase 4
• The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy VolunteersCompletedNCT04960657Not applicable
• A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy SubjectsCompletedNCT04859452Phase 1
• The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy VolunteersCompletedNCT04231617Not applicable
• Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult VolunteersCompletedNCT03856970Phase 1
• A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. )CompletedNCT03855306Phase 1
• Glibenclamide Advantage in Treating Edema After Intracerebral HemorrhageCompletedNCT03741530Not applicable
• Glibenclamide in Aneurysmatic Subarachnoid HemorrhageStatus unknownNCT03569540Phase 4
• Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral EmbolismCompletedNCT03284463Phase 2/3
• Failure Rate of GLyburide And Metformin Among Gestational DiabeticsWithdrawnNCT03078725Phase 4
• Low dosE GlibENclamide in Diabetes Part ACompletedNCT02830048Phase 2
• The Drug -Drug Interaction of SP2086 and GlyburideCompletedNCT02815787Phase 1
• Glyburide vs Glucovance in the Treatment of GDMTerminatedNCT02726490Early Phase 1
• Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP ChannelsCompletedNCT02375828Phase 3
• Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion InjuryStatus unknownNCT02255006Not applicable
• Bioavailability of BI 1356 and Glyburide in Healthy Male and Female VolunteersCompletedNCT02183428Phase 1
• Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and HypertensionCompletedNCT02145611Phase 4
• Cardioprotective Effects of GLP-1 and Their MechanismsCompletedNCT02128022Phase 1
• Oral Antidiabetic Agents in PregnancyStatus unknownNCT02091336Phase 4
• A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteSCompletedNCT02080377Phase 3
• Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 DiabetesStatus unknownNCT01867502Phase 4
• Glyburide Advantage in Malignant Edema and Stroke - Remedy PharmaceuticalsCompletedNCT01794182Phase 2
• A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy VolunteersCompletedNCT01733108Phase 1
• Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational DiabetesCompletedNCT01731431Phase 3
• Glyburide Healthy Volunteer StudyCompletedNCT01716338Phase 1
• Efficacy of Repaglinide in Subjects With Type 2 DiabetesCompletedNCT01698931Phase 4
• A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes MellitusCompletedNCT01563120Phase 4
• R230C and C230C Variants of ABCA1 and Glyburide ResponseCompletedNCT01456650Phase 4
• Glyburide (RP-1127) for Traumatic Brain Injury (TBI)CompletedNCT01454154Phase 2
• Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)CompletedNCT01329016Phase 1/2
• Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?CompletedNCT01215331Phase 3
• Safety Study of RP-1127 (Glyburide for Injection) in Healthy VolunteersCompletedNCT01132703Phase 1
• Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)WithdrawnNCT00935363Phase 1
• A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865436Phase 1
• A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting ConditionsCompletedNCT00865241Phase 1
• A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting ConditionsCompletedNCT00864734Phase 1
• Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
• The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and InflammationStatus unknownNCT00696982Not applicable
• Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes MellitusCompletedNCT00610038Phase 2
• Glimepiride Induced Insulin Secretion Will be Inhibited by HypoglycemiaCompletedNCT00608179Not applicable
• Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNCT00549874Not applicable
• Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DMCompletedNCT00515801Phase 2/3
• Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?Status unknownNCT00472875Phase 4
• Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 DiabetesCompletedNCT00451620Phase 2
• A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.CompletedNCT00388986Phase 1
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
• Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNCT00267683Phase 3
• GALLANT 4 Tesaglitazar vs. GlibenclamideTerminatedNCT00255541Phase 3
• Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational DiabetesWithdrawnNCT00160485Phase 4
• A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.CompletedNCT00035542Phase 3

← Glyburide overview